Trials / Enrolling By Invitation
Enrolling By InvitationNCT06332131
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study that includes patients with breast cancer or non-small cell lung cancer who will be treated with immune checkpoint inhibitor (ICI) therapy. The investigators will use echocardiograms, blood draws, and PET stress tests to understand how ICI therapy affects the heart and circulatory system.
Conditions
Timeline
- Start date
- 2025-01-15
- Primary completion
- 2026-07-01
- Completion
- 2026-07-01
- First posted
- 2024-03-27
- Last updated
- 2026-02-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06332131. Inclusion in this directory is not an endorsement.